Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Neuroendocrine × Radiotherapy × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 24 Prostatic Neoplasms 23 Glioblastoma 21 Squamous Cell Carcinoma of Head and Neck 18 Carcinoma, Non-Small-Cell Lung 17 Lung Neoplasms 14 Sarcoma 10 Head and Neck Neoplasms 10 Glioma 9 Brain Neoplasms 9 Rectal Neoplasms 8 Astrocytoma 8 Uterine Cervical Neoplasms 7 Neoplasms 7 Esophageal Neoplasms 6 Colorectal Neoplasms 5 Urinary Bladder Neoplasms 4 Pancreatic Neoplasms 4 Oropharyngeal Neoplasms 4 Oligodendroglioma 4 Neoplasm Metastasis 4 Nasopharyngeal Carcinoma 4 Melanoma 4 Carcinoma, Squamous Cell 4 Small Cell Lung Carcinoma 3 Sarcoma, Ewing 3 Recurrence 3 Radiation Injuries 3 Lymphoma, Follicular 3 Lymphoma 3

Interventions

atezolizumab 3 Etoposide 2 Cisplatin 2 zimberelimab 1 tivozanib 1 durvalumab 1 cabozantinib 1 belinostat 1 Temozolomide 1 Standard of Care 1 Positron Emission Tomography Computed Tomography 1 Nivolumab 1 Magnetic Resonance Imaging 1 Ipilimumab 1 Immunoglobulin G 1 Disulfides 1 Carboplatin 1 Capecitabine 1 CTLA-4 Antigen 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡